BioCryst Pharmaceuticals Inc

Watch

Share

DBSDF·006175203·US·equity·Financial Services - Banks - Regional

Common Stock - Domestic

DBSDF (BioCryst Pharmaceuticals Inc) is held by 1 institutional investors as of Q1 2026. Largest holders: Aristotle Capital Management, LLC ($127.7M), Pacer Advisors, Inc. ($15.6M).

1

Holders

Avg rating

$15.6M

Total Value

100% (1)

Fund Consensus

Smart Money Verdict

View all

60Mixed MomentumSingle Source

Institutional (13F)

No data

Insider (Form 4)

No data

Activist (13D/13G)

No data

Congressional (STOCK Act)60

Get 5 free verdicts/month - sign up in 10 seconds

See how DBSDF's score breaks down across 4 SEC sources

Holder Quality

0

★★★★★

Elite

1

★★★★

Strong

0

★★★

Solid

1

★★

Below

0

★

Weak

Held by 1 fund

Who's Trading

CongressGilbert CisnerosBuy $1,001 - $15,000Nov 20, 2025

13F: Mar 31, 2026Insider & Congress: Updated regularly

Positions (2)History

AllNewIncreasedHeldDecreasedExited

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
Aristotle Capital Management, LLC	Decreased	2.9M(-6.4%)	$127.7M	0.3%	+168.53%	0
Pacer Advisors, Inc.	Increased	1.6M(+103x)	$15.6M	0.0%	+13.98%	45